NPR
Key FDA committee unanimously recommends its first vaccine since 2023
All nine members of the committee unanimously voted to recommend Moderna's new mRNA influenza vaccine for adults 50 and over. (Image credit: Visoot Uthairam/Moment RF)
Related stories
The Hill
HealthJun 18, 2026 · 1 min
FDA panel recommends mRNA flu vaccine for older adults
The Hill
The Guardian
HealthJun 18, 2026 · 1 min
FDA panel considers a first-of-its-kind flu vaccine using mRNA technology
The Guardian
Ars Technica
ScienceJun 18, 2026 · 1 min
FDA advisors unanimously vote to approve Moderna's mRNA after agency drama
Ars Technica
Dawn
ScienceJun 6, 2026 · 1 min
First-ever AI-designed vaccine reaches human trials
Dawn